JP2014503525A5 - - Google Patents

Download PDF

Info

Publication number
JP2014503525A5
JP2014503525A5 JP2013543801A JP2013543801A JP2014503525A5 JP 2014503525 A5 JP2014503525 A5 JP 2014503525A5 JP 2013543801 A JP2013543801 A JP 2013543801A JP 2013543801 A JP2013543801 A JP 2013543801A JP 2014503525 A5 JP2014503525 A5 JP 2014503525A5
Authority
JP
Japan
Prior art keywords
compound according
group
alkyl
motomeko
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013543801A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014503525A (ja
JP5945278B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/073011 external-priority patent/WO2012080447A1/en
Publication of JP2014503525A publication Critical patent/JP2014503525A/ja
Publication of JP2014503525A5 publication Critical patent/JP2014503525A5/ja
Application granted granted Critical
Publication of JP5945278B2 publication Critical patent/JP5945278B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013543801A 2010-12-16 2011-12-16 呼吸合胞体ウイルスの抗ウイルス剤としてのインドール Active JP5945278B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10195468.3 2010-12-16
EP10195468 2010-12-16
PCT/EP2011/073011 WO2012080447A1 (en) 2010-12-16 2011-12-16 Indoles as respiratory syncytial virus antiviral agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016048038A Division JP2016145236A (ja) 2010-12-16 2016-03-11 呼吸合胞体ウイルスの抗ウイルス剤としてのインドール

Publications (3)

Publication Number Publication Date
JP2014503525A JP2014503525A (ja) 2014-02-13
JP2014503525A5 true JP2014503525A5 (enExample) 2014-07-10
JP5945278B2 JP5945278B2 (ja) 2016-07-05

Family

ID=43875270

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013543801A Active JP5945278B2 (ja) 2010-12-16 2011-12-16 呼吸合胞体ウイルスの抗ウイルス剤としてのインドール
JP2016048038A Pending JP2016145236A (ja) 2010-12-16 2016-03-11 呼吸合胞体ウイルスの抗ウイルス剤としてのインドール

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016048038A Pending JP2016145236A (ja) 2010-12-16 2016-03-11 呼吸合胞体ウイルスの抗ウイルス剤としてのインドール

Country Status (31)

Country Link
US (3) US8921560B2 (enExample)
EP (1) EP2651922B1 (enExample)
JP (2) JP5945278B2 (enExample)
KR (1) KR101914606B1 (enExample)
CN (1) CN103347875B (enExample)
AR (1) AR084335A1 (enExample)
AU (1) AU2011343256C1 (enExample)
BR (1) BR112013011949B1 (enExample)
CA (1) CA2822000C (enExample)
CL (1) CL2013001715A1 (enExample)
CY (1) CY1117763T1 (enExample)
DK (1) DK2651922T3 (enExample)
EA (1) EA022339B1 (enExample)
ES (1) ES2572258T3 (enExample)
HR (1) HRP20160533T1 (enExample)
HU (1) HUE028009T2 (enExample)
IL (1) IL225641A (enExample)
ME (1) ME02406B (enExample)
MX (1) MX339944B (enExample)
MY (1) MY163981A (enExample)
NZ (1) NZ609487A (enExample)
PH (1) PH12013500797A1 (enExample)
PL (1) PL2651922T3 (enExample)
RS (1) RS54746B1 (enExample)
SG (1) SG189866A1 (enExample)
SI (1) SI2651922T1 (enExample)
SM (1) SMT201600142B (enExample)
TW (1) TWI515187B (enExample)
UA (1) UA109792C2 (enExample)
WO (1) WO2012080447A1 (enExample)
ZA (1) ZA201304423B (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI527814B (zh) * 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
TWI501967B (zh) 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
TWI515187B (zh) * 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類
TWI541241B (zh) * 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
TWI530495B (zh) 2010-12-16 2016-04-21 健生科學愛爾蘭無限公司 苯并咪唑呼吸道融合病毒抑制劑
DK2864323T3 (en) * 2012-06-15 2017-08-14 Janssen Sciences Ireland Uc 1,3-DIHYDRO-2H-BENZIMIDAZOLE-2 UNDERIVATIVES SUBSTITUTED BY HETEROCYCLES AS ANTIVIRUS AGENTS AGAINST RESPIRATORY SYNCYTIAL VIRUS
JP2015519387A (ja) * 2012-06-15 2015-07-09 ヤンセン・アールアンドデイ・アイルランド Rsウイルス抗ウイルス薬としての、複素環によって置換された新規4−置換1,3−ジヒドロ−2h−ベンゾイミダゾル−2−オン誘導体
BR112015000392A2 (pt) * 2012-07-10 2017-06-27 Hoffmann La Roche novos indazóis para o tratamento e profilaxia da infecção por vírus sincicial respiratório
TWI598351B (zh) 2012-10-16 2017-09-11 健生科學愛爾蘭無限公司 Rsv抗病毒化合物
WO2015026792A1 (en) 2013-08-21 2015-02-26 Alios Biopharma, Inc. Antiviral compounds
TWI671299B (zh) 2014-04-14 2019-09-11 愛爾蘭商健生科學愛爾蘭無限公司 作為rsv抗病毒化合物之螺脲化合物
CA2957017A1 (en) * 2014-08-05 2016-02-11 Alios Biopharma, Inc. Combination therapy for treating a paramyxovirus
MA41614A (fr) 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux
TW201639811A (zh) 2015-03-13 2016-11-16 佛瑪治療公司 作為HDAC8抑制劑之α-桂皮醯胺化合物與組成物
SMT202200437T1 (it) 2015-07-22 2023-01-13 Enanta Pharm Inc Derivati benzodiazepinaci come inibitori del rsv
JP6964343B2 (ja) 2015-11-20 2021-11-10 フォーマ セラピューティクス,インコーポレイテッド ユビキチン特異的プロテアーゼ1阻害剤としてのプリノン
CN108699077B (zh) 2016-01-15 2021-03-02 英安塔制药有限公司 作为rsv抑制剂的杂环化合物
US10363253B2 (en) 2016-02-03 2019-07-30 Janssen Sciences Ireland Unlimited Company Combination products for the treatment of RSV
AU2017233739A1 (en) 2016-03-15 2018-09-20 Bayer Cropscience Aktiengesellschaft Substituted sulfonyl amides for controlling animal pests
TW201822637A (zh) 2016-11-07 2018-07-01 德商拜耳廠股份有限公司 用於控制動物害蟲的經取代磺醯胺類
KR102573499B1 (ko) 2017-02-16 2023-08-31 이난타 파마슈티칼스, 인코포레이티드 벤조디아제핀 유도체의 제조 방법
WO2019006295A1 (en) 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
JP7198811B2 (ja) 2017-09-29 2023-01-04 エナンタ ファーマシューティカルズ インコーポレイテッド Rsv阻害剤としての組み合わせ医薬剤
NZ764647A (en) 2017-11-13 2025-12-19 Enanta Pharm Inc Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives
TW201936193A (zh) 2017-12-05 2019-09-16 愛爾蘭商健生科學愛爾蘭無限公司 使用組合產品治療rsv
AU2020240024B2 (en) 2019-03-18 2025-06-26 Enanta Pharmaceuticals, Inc Benzodiazepine derivatives as RSV inhibitors
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
CN114761016A (zh) 2019-10-04 2022-07-15 英安塔制药有限公司 抗病毒杂环化合物
CA3152302A1 (en) * 2019-10-30 2021-05-06 Marcello Rasparini Synthesis of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1h-indol-2-yl} methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2h-imidazo[4,5c]pyridin-2-one
CA3151904A1 (en) * 2019-10-30 2021-05-06 Hongyu TAN Synthesis of 3-nitro-n-(2,2,2-trifluoroethyl)-4-pyridinamine
JP2023501978A (ja) 2019-11-07 2023-01-20 バイエル・アクチエンゲゼルシヤフト 動物害虫駆除用の置換スルホニルアミド
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
WO2021250180A1 (en) 2020-06-11 2021-12-16 Janssen Sciences Ireland Unlimited Company Hemi (l)-tartrate forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1h-indol-2 yl} methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one and pharmaceutical compositions comprising the same
WO2022010882A1 (en) 2020-07-07 2022-01-13 Enanta Pharmaceuticals, Inc, Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors
US11945824B2 (en) 2020-10-19 2024-04-02 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as anti-viral agents
JP7358657B2 (ja) 2020-10-28 2023-10-10 塩野義製薬株式会社 抗ウイルス活性を有するアミド誘導体
US11945830B2 (en) 2021-02-26 2024-04-02 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
WO2022184606A1 (en) 2021-03-01 2022-09-09 Janssen Sciences Ireland Unlimited Company Synthesis of rilematovir
CN114014856B (zh) * 2021-11-26 2023-12-22 嘉兴安谛康生物科技有限公司 作为呼吸道合胞病毒抗病毒剂的咪唑并吡啶类衍生物
AR129003A1 (es) 2022-04-07 2024-07-03 Enanta Pharm Inc Compuestos heterocíclicos antivirales
US12162857B2 (en) 2022-04-27 2024-12-10 Enanta Pharmaceuticals, Inc. Antiviral compounds
WO2024174953A1 (zh) * 2023-02-21 2024-08-29 苏州隆博泰药业有限公司 苯并咪唑类衍生物及其医药用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998001428A1 (en) 1996-07-08 1998-01-15 Du Pont Pharmaceuticals Company AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN
WO2000020400A1 (en) 1998-10-05 2000-04-13 Axys Pharmaceuticals, Inc. Novel compounds and compositions for treating hepatitis c infections
UA70976C2 (uk) 1998-12-18 2004-11-15 Аксіз Фармасьютікелз, Інк. (гетеро)арилбіциклічні гетероарильні похідні, їх одержання та використання як інгібіторів протеаз
TR200600172T2 (tr) 1999-06-28 2007-10-22 Janssen Pharmaceutica N.V Solunum sistemi sinsitiyal virüsünün replikasyonunu inhibe edici maddeler.
WO2001000612A2 (en) 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
AU6762400A (en) * 1999-08-12 2001-03-13 Cor Therapeutics, Inc. Inhibitors of factor xa
US20020019395A1 (en) * 2000-02-01 2002-02-14 Bing-Yan Zhu Indalone and benzimidazolone inhibitors of factor Xa
US20020072530A1 (en) * 2000-02-01 2002-06-13 Bing-Yan Zhu Indole and benzimidazole inhibitors of factor Xa
US6489338B2 (en) * 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) * 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
US6919331B2 (en) 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
HUP0402535A2 (hu) 2001-12-10 2005-04-28 Bristol-Myers Squibb Co. RSV fúzió inhibitor hatású imidazo-piridin-vegyület dihidroklorid-monohidrát sója és az ezt tartalmazó gyógyszerkészítmények
US20030180957A1 (en) 2001-12-21 2003-09-25 Sense Proteomic Limited Target and method
US20040166137A1 (en) 2002-11-08 2004-08-26 Lackey John William Hetero-substituted benzimidazole compounds and antiviral uses thereof
AR043692A1 (es) 2003-02-06 2005-08-10 Novartis Ag 2-cianopirrolopirimidinas y sus usos farmaceuticos
US7343930B2 (en) 2004-12-03 2008-03-18 Masco Corporation Of Indiana Sprayer with non-faucet control
MY140748A (en) 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
US9150556B2 (en) 2007-05-22 2015-10-06 Boehringer Ingelheim International Gmbh Benzimidazolone chymase inhibitors
FR2926556B1 (fr) * 2008-01-22 2010-02-19 Sanofi Aventis Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
TWI527814B (zh) * 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
TWI515187B (zh) * 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類
TWI501967B (zh) 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
TWI530495B (zh) * 2010-12-16 2016-04-21 健生科學愛爾蘭無限公司 苯并咪唑呼吸道融合病毒抑制劑
TWI541241B (zh) * 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
US20130261561A1 (en) 2010-12-17 2013-10-03 Sanofi-Aventis Deutschland Gmbh Medicament Administration
JP2015519387A (ja) 2012-06-15 2015-07-09 ヤンセン・アールアンドデイ・アイルランド Rsウイルス抗ウイルス薬としての、複素環によって置換された新規4−置換1,3−ジヒドロ−2h−ベンゾイミダゾル−2−オン誘導体
DK2864323T3 (en) 2012-06-15 2017-08-14 Janssen Sciences Ireland Uc 1,3-DIHYDRO-2H-BENZIMIDAZOLE-2 UNDERIVATIVES SUBSTITUTED BY HETEROCYCLES AS ANTIVIRUS AGENTS AGAINST RESPIRATORY SYNCYTIAL VIRUS
CA2873916A1 (en) 2012-06-15 2013-12-19 Janssen R&D Ireland 4-substituted 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with benzimidazoles as respiratory syncytial virus antivira agents
JP2015523350A (ja) 2012-06-15 2015-08-13 ヤンセン・アールアンドデイ・アイルランド Rsウイルス抗ウイルス薬としての、ベンゾイミダゾールによって置換された新規1,3−ジヒドロ−2h−ベンゾイミダゾル−2−オン誘導体
TWI598351B (zh) 2012-10-16 2017-09-11 健生科學愛爾蘭無限公司 Rsv抗病毒化合物

Similar Documents

Publication Publication Date Title
JP2014503525A5 (enExample)
JP2013545785A5 (enExample)
JP2016523955A5 (enExample)
JP2008509166A5 (enExample)
JP2016503793A5 (enExample)
JP2013537203A5 (enExample)
JP2015505296A5 (enExample)
JP2014500861A5 (enExample)
JP2012092103A5 (enExample)
JP2015537020A5 (enExample)
JP2014511892A5 (enExample)
JP2014506907A5 (enExample)
JP2013521295A5 (enExample)
JP2016506962A5 (enExample)
JP2014051526A5 (enExample)
JP2014500265A5 (enExample)
JP2018531941A5 (enExample)
JP2016530259A5 (enExample)
JP2011513410A5 (enExample)
JP2008540554A5 (enExample)
JP2018515563A5 (enExample)
JP2016510000A5 (ja) 治療用化合物
JP2016507575A5 (enExample)
JP2021501756A5 (enExample)
SI3102573T1 (en) SUBSTITUTED TIAZOL OR OXASOL AS ANTAGONISTS OF THE RECEPTOR P2X7